Rossari Biotech Limited (NSE:ROSSARI)

Rossari Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	39,009	37,399	32,878	50,189	53,775	-
Market Cap Growth	-2.54%	13.75%	-34.49%	-6.67%	-	-
Enterprise Value	39,817	37,924	32,853	49,805	52,708	-
Last Close Price	704.60	676.58	595.35	909.93	1033.28	-
PE Ratio	28.67	28.62	30.65	51.39	67.04	-
Forward PE	24.75	24.16	21.14	32.93	-	-
PS Ratio	1.98	2.04	1.99	3.38	7.58	-
PB Ratio	3.49	3.57	3.59	6.23	13.16	-
P/TBV Ratio	4.52	4.76	5.13	9.22	13.60	-
P/FCF Ratio	-	-	27.70	-	-	-
P/OCF Ratio	-	86.46	21.69	170.96	112.58	-
PEG Ratio	1.77	1.19	1.19	1.81	-	-
EV/Sales Ratio	2.02	2.07	1.98	3.36	7.43	-
EV/EBITDA Ratio	16.15	15.73	15.37	28.17	42.87	-
EV/EBIT Ratio	20.98	20.76	21.67	38.54	52.58	-
EV/FCF Ratio	-	-	27.68	-	-	-
Debt / Equity Ratio	0.14	0.11	0.08	0.01	-	0.23
Debt / EBITDA Ratio	0.65	0.49	0.34	0.05	-	0.64
Debt / FCF Ratio	-	-	0.62	-	-	-
Asset Turnover	-	1.25	1.26	1.63	1.37	1.66
Inventory Turnover	-	5.53	6.22	7.80	6.05	6.62
Quick Ratio	-	1.17	1.45	1.25	1.55	1.61
Current Ratio	-	1.99	2.07	2.07	2.36	2.19
Return on Equity (ROE)	-	13.32%	12.47%	16.10%	23.02%	31.79%
Return on Assets (ROA)	-	7.77%	7.22%	8.88%	12.13%	15.24%
Return on Capital (ROIC)	9.88%	10.60%	10.51%	13.21%	16.43%	22.81%
Return on Capital Employed (ROCE)	-	15.90%	14.90%	13.40%	24.40%	27.20%
Earnings Yield	3.49%	3.49%	3.26%	1.95%	1.49%	-
FCF Yield	-	-2.35%	3.61%	-0.18%	-0.19%	-
Dividend Yield	0.07%	0.07%	0.08%	0.06%	0.05%	-
Payout Ratio	-	2.11%	2.57%	2.82%	3.16%	4.06%
Buyback Yield / Dilution	-0.03%	0.05%	-0.33%	-6.37%	-5.16%	-1.91%
Total Shareholder Return	0.04%	0.13%	-0.24%	-6.31%	-5.12%	-1.91%

Updated Jan 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.